Immunotherapeutic Approaches for Alzheimer’s Disease

Wisniewski, Thomas, Goñi, Fernando·2015·Neuron
DOI 10.1016/j.neuron.2014.12.064

Cited by (284)

Items 201–284 of 284

  1. Immunomodulation via Toll-like Receptor 9: An Adjunct Therapy Strategy against Alzheimer's Disease?
    María Clara Sellés, Juliana T.S. Fortuna, Luís E. Santos · 2017 · Journal of Neuroscience
  2. Current status of vaccines in psychiatry—A narrative review
    Pooja Patnaik Kuppili, Harshini Manohar, Vikas Menon · 2018 · Asian Journal of Psychiatry
  3. Immunization with Small Amyloid-β-derived Cyclopeptide Conjugates Diminishes Amyloid-β-Induced Neurodegeneration in Mice
    Cornelis Kees Mulder, Yun Dong, Humphrey F. Brugghe, Hans Timmermans, Wichard Tilstra, Janny Westdijk, Elly van Riet, Harry VAN STEEG, Peter Hoogerhout, Ulrich L.M. Eisel · 2016 · Journal of Alzheimer s Disease
  4. Crosstalk between copper, Alzheimer’s disease, and melatonin
    Deepika, Ashima Thakur, Archna Panghal, Rajesh Pundir, Charan Singh, Manoj Goyal, Ajay Gajanan Namdeo, Jayant Kumar · 2025 · BioMetals
  5. Huannao Yicong Formula (还脑益聪方) regulates γ-secretase activity through APH-1 and PEN-2 gene ragulation pathways in hippocampus of APP/PS1 double transgenic mice
    Zhiyong Wang, Jiangang Liu, Yun Wei, Meixia Liu, Qi Wang, Lin Liang, Huimin Yang, Hao Li · 2017 · Chinese Journal of Integrative Medicine
  6. Emerging drugs for progressive supranuclear palsy
    Nikolaos Giagkou, María Stamelou · 2019 · Expert Opinion on Emerging Drugs
  7. Hippocampal neurons in direct contact with astrocytes exposed to amyloid β25-35 exhibit reduced excitatory synaptic transmission
    Kohei Oyabu, Hiroki Kiyota, Kaori Kubota, Takuya Watanabe, Shutaro Katsurabayashi, Katsunori Iwasaki · 2019 · IBRO Reports
  8. Innate Immunity Stimulation via Toll-Like Receptor 9 Ameliorates Vascular Amyloid Pathology in Tg-SwDI Mice with Associated Cognitive Benefits
    Henrieta Scholtzova, Eileen Do, Shleshma Dhakal, Yanjie Sun, Shan Liu, Pankaj D Mehta, Thomas Wısnıewskı · 2017 · Journal of Neuroscience
  9. Oral Immunization with Soybean Storage Protein Containing Amyloid-β 4–10 Prevents Spatial Learning Decline
    Takeshi Kawarabayashi, Teruhiko Terakawa, Atsushi Takahashi, Hisakazu Hasegawa, Sakiko Narita, Kaoru Sato, Takumi Nakamura, Yusuke Seino, Mie Hirohata, Nobue Baba et al. · 2019 · Journal of Alzheimer s Disease
  10. Vaccination strategies
    Thomas Wısnıewskı, Fernando Goñi · 2018 · Handbook of clinical neurology
  11. Hydrophilicity-Driven Modulation of Amyloid-β(1–40) Fibrillation by Engineered Nanomaterials
    Xuecheng Yang, Xiaoyu Zhang, Ge Yu, Yubin Ma, Xin Li, Yiyang Guo, Shuping Wang, Dan Ge, Changying Xue, Kun Jin et al. · 2025 · ACS Applied Materials & Interfaces
  12. Could routine vaccinations prevent dementia?
    E. Poynton-Smith, M. Orrell, J. Morley, Jeffrey F. Scherrer · 2023 · International Journal of Geriatric Psychiatry
  13. Pyrogallol intermediates elicit beta-amyloid secretion via radical formation and alterations in intracellular trafficking, distinct from pyrogallol-generated superoxide
    Bong-Geum Jang, Boyoung Choi, Min-Ju Kim · 2024 · Redox Biology
  14. Transmissible Spongiform Encephalopathies
    Thomas Wısnıewskı, Fernando Goñi · 2016 · Springer eBooks
  15. Progress and Challenges in the Development of PET Ligands to Aid CNS Drug Discovery
    J. Mercier, L. Provins, J. Hannestad · 2017 · Elsevier eBooks
  16. Self-Replication of Prion Protein Fragment 89-230 Amyloid Fibrils Accelerated by Prion Protein Fragment 107-143 Aggregates
    Tomas Šneideris, Mantas Žiaunys, Brett K.‐Y. Chu, Rita P.‐Y. Chen, Vytautas Smirnovas · 2020 · International Journal of Molecular Sciences
  17. Early Detection of Amyloid β Pathology in Alzheimer’s Disease by Molecular MRI
    Celia M. Dong, Audrey S. Guo, Anthea To, Kannie W. Y. Chan, Aviva S.F. Chow, Liming Bian, Alex T. L. Leong, Edward X. Wu · 2020 · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)
  18. Biologics for the management of dementia
    Akash Chaurasiya, Sumeet Katke, Kanan Panchal, Jayabalan Nirmal · 2022 · Elsevier eBooks
  19. Animal Model for Alzheimer’s Disease, Parkinson’s Disease, and Schizophrenia
    Dhanasekaran Sivaraman, Rathinam Arunadevi, Mohana Nandan, Krishnapriya Chandrababu, P. S. Baby Chakrapani, Unnikrishnan Sivan · 2024 · Springer eBooks
  20. Sheltering proteins from protease-mediated degradation and a de novo strategy for preventing acute liver injury
    Pengzhong Shi, Bojiao Tang, Sijie Zhou, Jianghui Qin, Xingjie Zan, Wujun Geng · 2021 · Biomaterials Science
  21. Active Humoral Response Reverts Tumorigenicity through Disruption of Key Signaling Pathway
    Tracer Yong, Ko‐Keng Chang, Yi‐Sheng Wang, Che Ma · 2022 · Vaccines
  22. Effects of insulin on transcriptional response and permeability in an in vitro model of human blood‐brain barrier
    Ziyu Kuai, Yan‐Ming Xu, Qi Zhao, Jie Liu, Shanshan Guan, Yongbo Qiao, Xin Gong, Jiaojiao Nie, Pengju Li, Dongni Liu et al. · 2018 · Journal of Cellular Biochemistry
  23. A coiled conformation of amyloid-β recognized by antibody C706
    A. Teplyakov, Galina Obmolova, Gary L. Gilliland · 2017 · Alzheimer s Research & Therapy
  24. Passive Immunization With a Novel Monoclonal Anti-PrP Antibody TW1 in an Alzheimer’s Mouse Model With Tau Pathology
    Allal Boutajangout, Wei Zhang, Justin Kim, Wed Abdali, Frances Prelli, Thomas Wısnıewskı · 2021 · Frontiers in Aging Neuroscience
  25. Acute targeting of N-terminal tau protein has long-lasting beneficial effects in Tg2576 APP/Aβ mouse model by reducing cognitive impairment, cerebral Aβ-amyloidosis, synaptic remodeling and microgliosis later in life
    Valentina Latina, Margherita De Introna, Francesca Malerba, Rita Florio, Bijorn Omar Balzamino, Giuseppe Di Natale, Michele F. M. Sciacca, Giuseppe Pappalardo, Alessandra Micera, Annabella Pignataro et al. · 2025 · Acta Neuropathologica Communications
  26. Prediction of the 3D conformation of a small peptide vaccine targeting Aβ42 oligomers
    Yvning Guan, Jinfei Mei, Xvzhi Gao, Chuanbo Wang, Mengke Jia, Sajjad Ahmad, Fahad Nouman Muhammad, Hongqi Ai · 2024 · Physical Chemistry Chemical Physics
  27. Flow‐cytometric screening of aggregation‐inhibitors using a fluorescence‐assisted intracellular method
    Hanna Lindberg, Lisa Sandersjöö, Sebastian W. Meister, Mathias Uhlén, John Löfblom, Stefan Ståhl · 2016 · Biotechnology Journal
  28. Effect and Potential Mechanism of Immunotherapy on Cognitive Deficits in Animal Models of Alzheimer's Disease: A Systematic Review and Meta-Analysis
    Zhenwei Zhai, Fanjing Kong, Zhishan Zhu, Jingyi Dai, Jie Cai, Danni Xie, Yuzhao Shen, Ying Xu, Tao Sun · 2023 · American Journal of Geriatric Psychiatry
  29. Targeting the immune system towards novel therapeutic avenues to fight brain aging and neurodegeneration
    Javier María Peralta Ramos, Denise Kviatcovsky, Michal Schwartz · 2022 · European Journal of Neuroscience
  30. Neural Regeneration as a Disease-Modifying Therapeutic Strategy for Alzheimer’s Disease
    Syed Faraz Kazim, Khalid Iqbal · 2017 · Elsevier eBooks
  31. Un implant bioactif pour prévenir la maladie d’Alzheimer
    Aurélien Lathuilière, Bernard Laurent Schneider · 2017 · médecine/sciences
  32. Immunotherapy in Alzheimer’s Disease
    Jyoti Gupta, Mehboob Hoque · 2019 · Springer eBooks
  33. Molecular interactions between monoclonal oligomer-specific antibody 5E3 and its amyloid beta cognates
    Massih Khorvash, Nick Blinov, Carol L. Ladner-Keay, Jie Lu, Judith M. Silverman, Ebrima Gibbs, Yu Tian Wang, Andriy Kovalenko, David Scott Wishart, Neil R. Cashman · 2020 · PLoS ONE
  34. Alzheimer’s Disease: An Insightful Review on the Future Trends of the Effective Therapeutics
    Afreen Hashmi, Vivek Srivastava, Syed Abul Kalam, Devesh Kumar Mishra · 2022 · IntechOpen eBooks
  35. Therapeutic approaches in proteinopathies
    Mohsen Nabi‐Afjadi, Bahareh Dabirmanesh, Vladimir Nikolaevich Uversky · 2024 · Progress in molecular biology and translational science
  36. Preclinical models of Alzheimer’s disease for identification and preclinical validation of therapeutic targets: from fine-tuning strategies for validated targets to new venues for therapy
    Bruno Vasconcelos, Matthew Bird, Ilie‐Cosmin Stancu, Dick Terwel, Ilse Dewachter · 2017 · Elsevier eBooks
  37. Structure of the Blood Brain Barrier and the Role of Transporters in the movement of substrates across the barriers
    Ankul Singh, Chitra Vellapandian · 2022 · Qeios
  38. Drug Discovery from Medicinal Plants against Alzheimer's Disease
    Mona M. Marzouk, Mai Mohammed Farid, Nesrine Mahmoud Hegazi, Shahira M. Ezzat · 2023 · Wiley eBooks
  39. Protein misfolding and neurodegeneration: Mechanisms, implications, and therapeutic strategies
    Asma Shah, Tharini Karthikeyan, Sheema Hashem, Rakesh Kumar, Ajaz Ahmad Bhat, Muzafar Ahmad Macha · 2025 · Advances in protein chemistry and structural biology
  40. Neuronal alkaline phosphatase promotes the spread of Tau-induced pathology, and its blockade prevents neurodegeneration and memory loss
    Lucía Soria-Tobar, Daniel Ouro Corredera, Laura Román-Valero, Félix Hernández, Prof. José Luis Millán, Beatriz Alvarez‐Castelao, Álvaro Sebastián‐Serrano, Paloma Aivar, Miguel Dı́az-Hernández · 2026 · Neurotherapeutics
  41. P2X7 receptor or TNAP genetic blockade prevents the reduction of neuronal CTCF detected in tauopathy
    Paloma Aivar, Álvaro Sebastián‐Serrano, África Vincelle-Nieto, Ana C. Collado-Cantero, Daniel Ouro Corredera, Lucía Soria-Tobar, Armando Reyes‐Palomares, Miguel Dı́az-Hernández · 2026 · Neuropharmacology
  42. Viral Gene Therapy for Central Nervous System Diseases
    Viveka Nand Yadav, Maria Graciela Castro, Pedro Ricardo Lowenstein · 2016 · Springer eBooks
  43. Ultrasound as a treatment modality for neurological diseases
    Gerhard Leinenga, Rebecca M. Nisbet, Jürgen Götz · 2017 · The Medical Journal of Australia
  44. [Progress of clinical trials in Alzheimer’s disease drugs].
    Ying Peng, Pingping Li, Lin Li, Yu Zhang, Wei-Zhen Hou, Dan-dan Cui, Jiang Li, Ling Wang, Qingli Wang, Xiaoliang Wang · 2016 · PubMed
  45. Heterogeneity in Cost-Effectiveness Analysis of Vaccination for Mild and Moderate Alzheimer’s Disease
    Chung‐Hsien Lin, Jean Ching‐Yuan Fann, Sam Li‐Sheng Chen, Hsiu-Hsi Chen, Kuen‐Cheh Yang · 2019 · Current Alzheimer Research
  46. Do phagocytotic mechanisms regulate soluble factor secretion in microglia?
    Gen Hamanaka, Kelly K. Chung, Ken Arai · 2020 · Neural Regeneration Research
  47. Traumatic Brain Injury and Alzheimer’s Disease: Exploring the Pathological Overlap and Risk of Neurodegeneration
    Ioannis Asterios Mavroudis, Foivos Petridis, Dimitrios A. Kazis, Cătălina Ionescu, Bogdan Novac, Antoneta Dacia Petroaie, Otilia Novac, Irina Luciana Gurzu, Bogdan Gurzu · 2025 · BRAIN BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE
  48. Enfermedades neurodegenerativas y vacunas
    J. Vidal · 2017 · Vacunas
  49. Early Aβ-HBc virus-like particles immunization had better effects on preventing the deficit of learning and memory abilities and reducing cerebral Aβ load in PDAPP mice
    Gaifeng Feng, Caifeng Zheng, Jianjun Hui · 2018 · Vaccine
  50. Molecular Network for Management of Neurodegenerative Diseases and their Translational Importance using Animal Biotechnology as a Tool in Preclinical Studies
    Nibedita Naha · 2020 · Elsevier eBooks
  51. The Role of Polyphenols in the Treatment of Alzheimer's Disease: Narrative Review
    Reem Halim Alattiya, Farah Khalid Tarish, Lina Loai Hashim, Saad Abdulrahman Hussain · 2021 · Al-Rafidain Journal of Medical Sciences
  52. Alzheimer-Like Cell Alterations after Vanadium Pentoxide Inhalation
    Claudia Dorado-Martı́nez, Enrique Montiel-Flores, Oscar A. Mejía-García, José Luis Ordóñez-Librado, Ana Luisa Gutiérrez-Valdez, Jesús Espinosa-Villanueva, Leonardo Reynoso Erazo, Rocío Tron-Alvarez, Vianey Rodríguez-Lara, María Rosa Ávila-Costa · 2021 · IntechOpen eBooks
  53. Laboratory diagnostics in dementia
    Thomas Weber · 2018 · Journal of Laboratory Medicine
  54. Impact of Physical Exercise on the Hippocampal Pathology and Cognition in a Mouse Model of Alzheimer's Disease
    Ewelina Maliszewska‐Cyna · 2016 · TSpace (University of Toronto)
  55. The dynamic nature of amyloid-beta protein aggregation and its association to Alzheimer’s disease
    Sílvia Vilaprinyó-Pascual · 2015 · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
  56. Dear colleagues and friends!
    A. A. Volkov · 1997 · Journal of obstetrics and women s diseases
  57. Neurodegenerative diseases and vaccines
    J. Vidal · 2017 · Vacunas (English Edition)
  58. Therapeutic strategies for neurodegenerative disorders
    Yun Dong · 2017 · University of Groningen research database (University of Groningen / Centre for Information Technology)
  59. "Commentary: The ageing as a therapeutic target for Alzheimer's disease"
    Rafael Castro-Fuentes · 2017 · Journal of Neurology and Neuromedicine
  60. Magnetic resonance imaging and spectroscopy in at-risk populations and preclinical Alzheimer's disease
    Olga Voevodskaya · 2018 · Figshare
  61. Present and Future Therapies for Alzheimer’s Disease
    Hisashi Nagase, Kohzo Nakayama · 2018 · InTech eBooks
  62. The Blood-Brain Barrier as a Therapeutic Target for Alzheimer’s Disease and Related Disorders
    Sweilem B. Al Rihani · 2019
  63. Top ten discoveries of the year: Neuroinflammation
    Hans Lassmann · 2019 · Free Neuropathology
  64. Naturally Occurring Antibodies Against Bim Are Decreased in Alzheimer’s Disease and Attenuate Ad-type Pathologies in a Mouse Model
    Jie-Ming Jian, Dong‐Yu Fan, Ding‐Yuan Tian, Yuan Cheng, Pu‐Yang Sun, Gui‐Hua Zeng, Chen-Yang He, Ye‐Ran Wang, Jie Zhu, Xiu‐Qing Yao et al. · 2021 · Research Square
  65. Exploring the Efficacy of Anti-amyloid-β Therapeutics in Treating Alzheimer Disease
    Ciara Downey · 2022 · Youth STEM Matters
  66. Faculty Opinions recommendation of Reversal of paralysis and reduced inflammation from peripheral administration of β-amyloid in TH1 and TH17 versions of experimental autoimmune encephalomyelitis.
    John A. Lowe III · 2012 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  67. Caracterização preliminar do isolamento de oligômeros do peptídeo β-amiloide utilizando o anticorpo de cadeia única NUsc1
    Raquel Maria de Campos · 2018
  68. A Review on the Techniques for Early Diagnosis of Alzheimer’s Disease
    Maria Shahzadi, Bareera Saeed, Muhammad Azzam Khan, Amna Rashid, Muhammad Bilal, Roma Imtiaz, Tallat Anwar Faridi · 2022 · Lahore Garrison University Journal of Life Sciences
  69. Immunomodulation
    Thomas Wısnıewskı, Fernando Goñi · 2023 · Springer eBooks
  70. An Alzheimer's Vaccine Targeting Abeta Oligomer Shows Promise in Mouse Study
    Dan Hurley · 2023 · Neurology Today
  71. Lateral flow assay for early diagnosis of neurodegenerative disorder
    Tarun Kumar Kumawat, Arpana Parihar, Varsha Kumawat, Vishnu Lal Sharma, Anjali Pandit, Bhoomika Sharma, Manish Biyani · 2023 · Elsevier eBooks
  72. Programação fetal
    Gabriel Boer Grigoletti-Lima · 2020
  73. Enfermedad de Alzheimer: reporte de caso
    Rosa Beatriz Morocho Saquinaula, Rosa Veronica Sumba Portilla, Rodrigo José Mendoza Rivas · 2024 · Anatomía Digital
  74. Treatment strategies used for Alzheimer's disease
    Koyel Kar · 2024 · Elsevier eBooks
  75. Histopathological and Behavioral Irreversible Damage Derived from Chronic Exposure to Vanadium Pentoxide Is Similar to that Found in Alzheimer’s Disease
    María Rosa Ávila-Costa, Claudia Dorado-Martı́nez, Enrique Montiel-Flores, José Luis Ordóñez-Librado, Ana Luisa Gutiérrez-Valdez, Cesar Alfonso Garcia Caballero, Javier Sánchez-Betancourt, Leonardo Reynoso Erazo, Rocío Tron-Alvarez, Vianey Rodríguez-Lara et al. · 2024 · IntechOpen eBooks
  76. Additional file 1 of Photoactivation of TGFβ/SMAD signaling pathway ameliorates adult hippocampal neurogenesis in Alzheimer’s disease model
    Xiaolei Wu, Qi Shen, Zhan Zhang, Di Zhang, Ying Gu, Xing, Da · 2021 · Figshare
  77. Neuroimmune Signalling: Novel Emerging Options to Treat Neurodegeneration
    Ashwani Sharma, Bhaskaranand Pancholi, Anjali Sharma, Debapriya Garabadu · 2026 · Springer eBooks
  78. Plasma Autoantibodies Against Neurodegeneration-Related Antigens in Dementia and Elevated Chi3Li Autoantibodies in Mild Cognitive Impairment
    Gabriela Kocurova, Zuzana Svabenska, Jan Klaschka, Aleš Bartoš, Jan Říčný · 2026 · Biomolecules
  79. Les cellules souches olfactives ecto-mésenchymateuses en médecine régénérative : translation du potentiel thérapeutique du laboratoire à la clinique
    Antoine D. Véron · 2017
  80. MT5-MMP promotes neuroinflammation, pathogenic processing of amyloid precursor protein and synaptic dysfunction at early stages in an Alzheimer's disease model
    Dominika Piłat · 2021 · theses.fr (ABES)
  81. Advancements in Gene Delivery using Nucleic Acid Loaded Nanoparticles for Region Specific Delivery in Alzheimer’s Disease
    Vanktesh Kumar, Violina Kakoty, Pankaj K. Wadhwa · 2026 · Molecular Neurobiology
  82. Glycopolymers as emerging modulators of Amyloid-β aggregation: structure-activity relationships and therapeutic potential
    Emanuel Cardoso, Arménio Coimbra Serra, Jorge F. J. Coelho, Patrícia Pereira · 2026 · Carbohydrate Polymers
  83. THERAPY FOR ALZHEIMER’S DISEASE - FOCUS ON LECANEMAB
    Mikołaj Jońca, Gabriela Majchrowicz, Natasza Kurys, Weronika Piekarska, Szymon Litke, Katarzyna Gołacka · 2026 · International Journal of Innovative Technologies in Social Science
  84. The role of acupuncture in the dendritic cell vaccine against Alzheimer's disease
    Yuzhu Hong, Ning Shen, Haiqiang Yang, Ghufran Ahmed, Deepika Regmi, Xiaoyang Lin, Ningyi Guo, Grace Hearn, Darrell R. Sawmiller, Chuanhai Cao · 2026 · Journal of Alzheimer s Disease